Real world experience of hypofractionated radical radiotherapy for non-small cell lung cancer (NSCLC) during the COVID-19 pandemic: a well-tolerated radiotherapy schedule with acceptable progression-free (PFS) and overall survival (OS)

Saved in:
Bibliographic Details
Published inLung cancer (Amsterdam, Netherlands) Vol. 178; p. S63
Main Authors Jeyin, Nidhish, Kidane, Ghirmay, Withers, Dominic, Ball, Simon, Tarver, Kathryn
Format Journal Article
LanguageEnglish
Published Elsevier B.V. Published by Elsevier B.V 01.04.2023
Subjects
Radiotherapy
Online AccessGet full text

Cover

More Information
ISSN:0169-5002
1872-8332
DOI:10.1016/S0169-5002(23)00572-X